Sunmax Biotechnology Market Cap

Sunmax Biotechnology has a market cap or net worth of 21.16 billion as of April 28, 2026. Its market cap has increased by 4.16% in one year.

Market Cap

21.16B

Enterprise Value

20.32B

Revenue

2.03B

Ranking

n/a

PE Ratio

29.19

Stock Price

388.50

Market Cap Chart

Since January 25, 2010, Sunmax Biotechnology's market cap has increased from 1.49B to 21.16B, an increase of 1,322.84%. That is a compound annual growth rate of 17.73%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	21.16B	-1.89%
Dec 31, 2025	21.57B	41.43%
Dec 30, 2024	15.25B	37.25%
Dec 29, 2023	11.11B	50.00%
Dec 30, 2022	7.41B	64.65%
Dec 30, 2021	4.50B	2.61%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Lumosa Therapeutics	21.10B
Oneness Biotech	25.16B
AP Biosciences	16.30B
Medigen Vaccine Biologics	15.94B
Polaris Group	15.05B
EirGenix	13.95B
Lin BioScience	33.92B
TaiMed Biologics	13.20B

Market Cap Rankings